Pharmagreen Biotech's market cap is currently ―. The company's EPS TTM is $-0.001; its P/E ratio is ―; Pharmagreen Biotech is scheduled to report earnings on December 19, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Income Statement	-
Total Revenue	$ 501.00	$ 615.00	$ 1.06K	$ 1.24K	$ 1.44K
Gross Profit	$ 126.00	$ 131.00	$ 722.00	$ 757.00	$ 744.00
EBIT	$ -770.76K	$ -34.58K	$ -29.50K	$ -136.36K	$ -147.30K
EBITDA	$ -770.76K	$ -34.58K	$ -29.50K	$ -136.36K	$ -147.30K
Net Income Common Stockholders	$ -779.07K	$ -42.52K	$ -37.95K	$ -144.85K	$ -178.51K
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 276.00	$ 246.00	$ 560.00	$ 743.00	$ 1.25K
Total Assets	$ 97.68K	$ 97.92K	$ 103.81K	$ 112.43K	$ 121.57K
Total Debt	$ 220.43K	$ 219.03K	$ 355.36K	$ 356.70K	$ 372.84K
Net Debt	$ 220.15K	$ 218.78K	$ 354.80K	$ 355.96K	$ 371.59K
Total Liabilities	$ 3.23M	$ 2.43M	$ 2.41M	$ 2.42M	$ 2.30M
Stockholders Equity	$ -3.09M	$ -2.28M	$ -2.26M	$ -2.26M	$ -2.13M
Cash Flow	-
Free Cash Flow	-	-	$ -26.51K	$ -1.98K	$ -27.59K
Operating Cash Flow	$ 1.06K	$ -655.00	$ -26.51K	$ -1.98K	$ -27.59K
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	$ -1.00	$ 521.00	$ 28.03K	-	$ -589.00

Currency in USD

Pharmagreen Biotech Earnings and Revenue History

Income Statement >

Pharmagreen Biotech Debt to Assets

Balance Sheet >

Pharmagreen Biotech Cash Flow

Cash Flow >

Pharmagreen Biotech Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing